Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Remune phase II trial interim results

Sep. 27, 1996

Anti-HIV agents reported by Japanese researchers

Sep. 27, 1996

Clinical results with VIMRxyn in AIDS

Sep. 27, 1996

A novel mechanism for inhibiting HIV infection using fibronectin fragments

Sep. 27, 1996

Animal and human results presented on Aronex's lead anti-HIV integrase inhibitor

Sep. 27, 1996

Ciba characterizes another novel HIV protease inhibitor

Sep. 27, 1996

U.K. introduction for lamivudine

Sep. 27, 1996

Novel class of HIV protease inhibitors with improved activity

Sep. 27, 1996

Anti-HIV research continues at Boehringer Ingelheim

Sep. 27, 1996

Anti-HIV bicyclic phosphoramides from DuPont Merck

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...